ChemoTech signs a new cooperation agreement

ChemoTech has signed a cooperation agreement with Dr Jaime Rojo, a doctor at ACE Medical Center – Baypointe Hospital in the Philippines. Baypointe Hospital shall provide the best health and medical care with compassion, employing advanced technology and dedicated professionals, placing the patient’s well – being its highest priority.

The partnership agreement with Dr Rojo is aimed for commercial introduction and training of IQWave™. Dr Rojo will actively participate in promoting IQWave™ to more hospitals within the ACE Medical Center Group of Hospitals, where among others Baypointe Hospital is included.

This day marks a milestone in ChemoTech's history in the Philippines, when we have signed a cooperation agreement with our new KOL Dr Jaime Rojo from ACE Medical Center BayPointe. The hospital purchased an IQWave™ in early February and has begun treating its cancer patients with ChemoTech's Dynamic-ElectroEnhanced Chemotherapy™ (D-EECT).

Dr Rojo, a leading KOL in this area, will be an important resource for promoting D-EECT in the country. I'm glad to be part of this new technology, which significantly improves our ability to treat cancer patients," says Dr Rojo. During the recent visit by ChemoTech's CEO Mohan Frick, he repeated his commitment to support the company's vision for the fight against cancer, the "emperor of all maladies".

 
For more information, please contact:

Mohan Frick, CEO

+46 (0)10-218 93 00

info@chemotech.se

Scandinavian ChemoTech AB (publ)

www.chemotech.se

ChemoTech is a young and dynamic life science company that possesses a great medical expertise and technical knowledge. Our latest launch of IQWave™ is an innovation within electrochemotherapy, that is adapted for the treatment of different types of tumors. ChemoTech strives to contribute to a more accessible cancer care. ChemoTech's shares (CMOTEC B) are listed on NASDAQ First North in Stockholm and Västra Hamnen Corporate Finance AB is the company's Certified Adviser. The company is headquartered in Malmö, in the midst of the medical technology expansionary Öresund region.